Some non-conventional biomolecular targets for diamidines. A short survey
Copyright © 2014 Elsevier Ltd. All rights reserved..
Increasing the affinity of diamidines for AT-rich regions of DNA has long been an important goal of medicinal chemists who wanted to improve the antiparasitic and antifungal properties of that class of derivatives. In recent years it was demonstrated that diamidines could interfere with many other biomolecular targets including ion channels as well as enzymes and modulate some RNA-protein, DNA-protein, and protein-protein interactions. It is therefore not surprising that diamidines now emerge as novel potential drug candidates for the treatment of various diseases, i.a. neurodegenerative disorders, acidosis-related pathological conditions, hypertension, thrombosis, type 2 diabetes, myotonic dystrophy, and cancers. A summary of the most striking results obtained to date in those domains is presented is this review.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Bioorganic & medicinal chemistry - 22(2014), 7 vom: 01. Apr., Seite 1983-92 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Huang, Tien L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
63231-63-0 |
|---|
| Anmerkungen: |
Date Completed 25.11.2014 Date Revised 31.03.2014 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bmc.2014.02.049 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM236410172 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM236410172 | ||
| 003 | DE-627 | ||
| 005 | 20231224105516.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bmc.2014.02.049 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0788.xml |
| 035 | |a (DE-627)NLM236410172 | ||
| 035 | |a (NLM)24630693 | ||
| 035 | |a (PII)S0968-0896(14)00155-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Huang, Tien L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Some non-conventional biomolecular targets for diamidines. A short survey |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.11.2014 | ||
| 500 | |a Date Revised 31.03.2014 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2014 Elsevier Ltd. All rights reserved. | ||
| 520 | |a Increasing the affinity of diamidines for AT-rich regions of DNA has long been an important goal of medicinal chemists who wanted to improve the antiparasitic and antifungal properties of that class of derivatives. In recent years it was demonstrated that diamidines could interfere with many other biomolecular targets including ion channels as well as enzymes and modulate some RNA-protein, DNA-protein, and protein-protein interactions. It is therefore not surprising that diamidines now emerge as novel potential drug candidates for the treatment of various diseases, i.a. neurodegenerative disorders, acidosis-related pathological conditions, hypertension, thrombosis, type 2 diabetes, myotonic dystrophy, and cancers. A summary of the most striking results obtained to date in those domains is presented is this review | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Amidines | |
| 650 | 4 | |a Enzymes | |
| 650 | 4 | |a Ions channels | |
| 650 | 4 | |a Nucleic acid–protein interactions | |
| 650 | 4 | |a Protein–protein interactions | |
| 650 | 7 | |a Amidines |2 NLM | |
| 650 | 7 | |a Enzymes |2 NLM | |
| 650 | 7 | |a Ion Channels |2 NLM | |
| 650 | 7 | |a Proteins |2 NLM | |
| 650 | 7 | |a RNA |2 NLM | |
| 650 | 7 | |a 63231-63-0 |2 NLM | |
| 650 | 7 | |a DNA |2 NLM | |
| 650 | 7 | |a 9007-49-2 |2 NLM | |
| 700 | 1 | |a Mayence, Annie |e verfasserin |4 aut | |
| 700 | 1 | |a Vanden Eynde, Jean Jacques |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry |d 1994 |g 22(2014), 7 vom: 01. Apr., Seite 1983-92 |w (DE-627)NLM074978543 |x 1464-3391 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2014 |g number:7 |g day:01 |g month:04 |g pages:1983-92 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bmc.2014.02.049 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2014 |e 7 |b 01 |c 04 |h 1983-92 | ||